Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.412 DKK 0.14% Market Closed
Market Cap: 642m DKK

Wall Street
Price Targets

BIOPOR Price Targets Summary
Bioporto A/S

Wall Street analysts forecast BIOPOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOPOR is 4.08 DKK with a low forecast of 4.04 DKK and a high forecast of 4.2 DKK.

Lowest
Price Target
4.04 DKK
186% Upside
Average
Price Target
4.08 DKK
189% Upside
Highest
Price Target
4.2 DKK
197% Upside
Bioporto A/S Competitors:
Price Targets
VYGR
Voyager Therapeutics Inc
396% Upside
ELIC
Elicera Therapeutics AB
11% Upside
NVAX
Novavax Inc
137% Upside
LTRN
Lantern Pharma Inc.
589% Upside
DBV
DBV Technologies SA
187% Upside
ABBV
Abbvie Inc
16% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
45% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
18% Upside

Revenue
Forecast

Revenue Estimate
Bioporto A/S

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 7%. The projected CAGR for the next 1 year is 46%.

7%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOPOR's stock price target?
Price Target
4.08 DKK

According to Wall Street analysts, the average 1-year price target for BIOPOR is 4.08 DKK with a low forecast of 4.04 DKK and a high forecast of 4.2 DKK.

What is Bioporto A/S's Revenue forecast?
Projected CAGR
46%

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 7%. The projected CAGR for the next 1 year is 46%.

Back to Top